Extracellular Cold-Inducible RNA-Binding Protein: Progress from Discovery to Present.

Area of Science:

• Immunology
• Molecular Biology
• Biochemistry

Background:

• Extracellular cold-inducible RNA-binding protein (eCIRP) is identified as a damage-associated molecular pattern (DAMP).
• eCIRP plays a significant role in inflammation and tissue damage observed in hemorrhagic and septic shock.
• It has emerged as a potential therapeutic target and biomarker in various disease models.

Purpose of the Study:

• To provide a comprehensive review of eCIRP.
• To detail its discovery, role in disease pathophysiology, and mechanisms of release and action.
• To explore its potential as a biomarker and therapeutic strategies in inflammatory and ischemic diseases.

Main Methods:

• Literature review of preclinical disease models and patient materials.
• Examination of molecular, cellular, and immunological mechanisms of eCIRP.
• Analysis of emerging research and therapeutic strategies targeting eCIRP.

Main Results:

• eCIRP is implicated in driving inflammatory responses across diverse conditions.
• Mechanisms of eCIRP release and action are elucidated.
• Therapeutic strategies targeting eCIRP show promise in preclinical models.

Conclusions:

• eCIRP is a critical mediator of inflammation and tissue injury.
• It holds significant potential as both a biomarker and a therapeutic target.
• Further research into eCIRP-targeting strategies is warranted for conditions like shock, ischemia-reperfusion injury, and neurodegenerative diseases.